Korea Investment CORP Buys 11,500 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Korea Investment CORP grew its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 60.1% in the fourth quarter, Holdings Channel reports. The fund owned 30,630 shares of the company’s stock after acquiring an additional 11,500 shares during the quarter. Korea Investment CORP’s holdings in Molina Healthcare were worth $8,915,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of MOH. True Wealth Design LLC lifted its stake in Molina Healthcare by 2,500.0% in the third quarter. True Wealth Design LLC now owns 104 shares of the company’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Versant Capital Management Inc lifted its position in shares of Molina Healthcare by 83.1% during the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new position in shares of Molina Healthcare during the 4th quarter worth $52,000. EverSource Wealth Advisors LLC increased its holdings in Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock worth $57,000 after acquiring an additional 88 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its stake in Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company’s stock valued at $58,000 after acquiring an additional 155 shares during the period. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Price Performance

NYSE:MOH opened at $329.44 on Tuesday. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $409.07. The stock has a fifty day moving average of $303.84 and a 200 day moving average of $308.59. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The firm has a market capitalization of $18.02 billion, a price-to-earnings ratio of 16.13, a P/E/G ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, research analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analyst Ratings Changes

MOH has been the subject of a number of research reports. Barclays cut their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating for the company in a research report on Friday, February 7th. Truist Financial cut their price objective on shares of Molina Healthcare from $370.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, February 19th. Mizuho lowered their target price on shares of Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Stephens reaffirmed an “equal weight” rating and issued a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Finally, StockNews.com upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Wednesday, March 26th. Six analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $348.75.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.